Nadim Ahmed, President and CEO at Cullinan Therapeutics, Inc. (CGEM), sold 13,515 shares at $14.47 ($196K) on 2026-02-24, disclosed to the SEC on 2026-02-25.
Seasonal sale ($196k) by President and CEO — this insider has traded CGEM in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CGEM | SELL | 2025-02-27 | $214K | — | Filing → |
| CGEM | SELL | 2024-12-27 | $100K | — | Filing → |
| CGEM | SELL | 2023-12-27 | $39K | — | Filing → |